Mифортик (Mycophenolic Acid)

Mycophenolic Acid, the active ingredient in Mифортик, is an immunosuppressant presented as an oral formulation for oral use. It is employed to prevent organ transplant rejection and to treat certain autoimmune conditions such as lupus nephritis.\n\nGNH India supplies Mифортик as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Mифортик is an immunosuppressive agent used in conditions where the immune system must be moderated.\n\nOrgan transplant rejection: helps prevent graft rejection in transplant recipients.\nLupus nephritis: reduces kidney inflammation and disease progression in patients with systemic lupus erythematosus.\nOther autoimmune diseases: may be employed to control disease activity in selected autoimmune disorders under specialist supervision.

Mифортик may cause a range of adverse reactions, from mild to severe.\n\nCommon Side Effects:\n- Nausea: occasional upset stomach or feeling sick.\n- Diarrhea: loose stools that may affect hydration.\n- Headache: mild to moderate head pain.\n- Abdominal pain: discomfort or cramping in the stomach area.\n- Vomiting: occasional expulsion of stomach contents.\n- Fatigue: feeling unusually tired or weak.\n\nSerious or Rare Side Effects:\n- Bone marrow suppression: reduced blood cell counts leading to anemia or infection risk.\n- Severe infections: opportunistic infections due to immune suppression.\n- Hepatic toxicity: liver enzyme elevations or hepatitis.\n- Malignancy: increased long‑term risk of certain cancers, such as lymphomas.

Before initiating Mифортик, several safety considerations should be reviewed.\n\nRenal function: monitor serum creatinine and adjust therapy as needed.\nHepatic function: assess liver enzymes regularly.\nInfection risk: evaluate for active infections and avoid live vaccines.\nPregnancy and lactation: safety unknown; avoid unless benefits outweigh risks.\nDrug monitoring: periodic complete blood counts to detect bone marrow effects.\nStore at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Mифортик can interact with several medicines, requiring careful management.\n\nMajor Interactions (Avoid):\n- Azathioprine: additive bone marrow suppression may be dangerous.\n- Live vaccines: increased risk of severe infection; should not be administered.\n\nModerate Interactions (Monitor Closely):\n- Cyclosporine or tacrolimus: may raise mycophenolic acid concentrations, requiring dose adjustment.\n- Antacids containing aluminum or magnesium: can reduce oral absorption; separate dosing by at least 2 hours.\n- Warfarin: may potentiate anticoagulant effect, necessitating INR monitoring.